aluates Reports

$ 0.0

Automative

Poliovirus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-1F745

Global Poliovirus Vaccine Market Professional Survey Report 2019

BUY CHAPTERS

Poliovirus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-1F745

Report

September 2024

Pages:103

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

GSK

Bibcol

Serum Institute

Tiantan biological

IMBCA

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Poliovirus Vaccine - Market Size

The global market for Poliovirus Vaccine was estimated to be worth US$ 709.8 million in 2023 and is forecast to a readjusted size of US$ 955.4 million by 2030 with a CAGR of 4.4% during the forecast period 2024-2030

Poliovirus Vaccine - Market

Polio vaccines are vaccines used to prevent poliomyelitis (polio).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Poliovirus Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Poliovirus Vaccine by region & country, by Type, and by Application.

The Poliovirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliovirus Vaccine.

Market Segmentation

Scope of Poliovirus Vaccine - Market Report

Report Metric	Details
Report Name	Poliovirus Vaccine - Market
Forecasted market size in 2030	US$ 955.4 million
CAGR	4.4%
Forecasted years	2024 - 2030
Segment by Type:	Inactivated Polio Vaccine (IPV) Oral Polio Vaccine (OPV)
Segment by Application	Public Private
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Poliovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Poliovirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Poliovirus Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Poliovirus Vaccine - Market size in 2030?

Ans: The Poliovirus Vaccine - Market size in 2030 will be US$ 955.4 million.

Who are the main players in the Poliovirus Vaccine - Market report?

Ans: The main players in the Poliovirus Vaccine - Market are Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals

What are the Application segmentation covered in the Poliovirus Vaccine - Market report?

Ans: The Applications covered in the Poliovirus Vaccine - Market report are Public, Private

What are the Type segmentation covered in the Poliovirus Vaccine - Market report?

Ans: The Types covered in the Poliovirus Vaccine - Market report are Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)

Recommended Reports

Human Vaccines

Vaccine Delivery

Vaccine Technology

1 Market Overview

1.1 Poliovirus Vaccine Product Introduction

1.2 Global Poliovirus Vaccine Market Size Forecast

1.2.1 Global Poliovirus Vaccine Sales Value (2019-2030)

1.2.2 Global Poliovirus Vaccine Sales Volume (2019-2030)

1.2.3 Global Poliovirus Vaccine Sales Price (2019-2030)

1.3 Poliovirus Vaccine Market Trends & Drivers

1.3.1 Poliovirus Vaccine Industry Trends

1.3.2 Poliovirus Vaccine Market Drivers & Opportunity

1.3.3 Poliovirus Vaccine Market Challenges

1.3.4 Poliovirus Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Poliovirus Vaccine Players Revenue Ranking (2023)

2.2 Global Poliovirus Vaccine Revenue by Company (2019-2024)

2.3 Global Poliovirus Vaccine Players Sales Volume Ranking (2023)

2.4 Global Poliovirus Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Poliovirus Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Poliovirus Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Poliovirus Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Poliovirus Vaccine

2.9 Poliovirus Vaccine Market Competitive Analysis

2.9.1 Poliovirus Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Poliovirus Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliovirus Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Inactivated Polio Vaccine (IPV)

3.1.2 Oral Polio Vaccine (OPV)

3.2 Global Poliovirus Vaccine Sales Value by Type

3.2.1 Global Poliovirus Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Poliovirus Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Poliovirus Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Poliovirus Vaccine Sales Volume by Type

3.3.1 Global Poliovirus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Poliovirus Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Poliovirus Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Poliovirus Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Public

4.1.2 Private

4.2 Global Poliovirus Vaccine Sales Value by Application

4.2.1 Global Poliovirus Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Poliovirus Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Poliovirus Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Poliovirus Vaccine Sales Volume by Application

4.3.1 Global Poliovirus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Poliovirus Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Poliovirus Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Poliovirus Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Poliovirus Vaccine Sales Value by Region

5.1.1 Global Poliovirus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Poliovirus Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Poliovirus Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Poliovirus Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Poliovirus Vaccine Sales Volume by Region

5.2.1 Global Poliovirus Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Poliovirus Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Poliovirus Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Poliovirus Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Poliovirus Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Poliovirus Vaccine Sales Value, 2019-2030

5.4.2 North America Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Poliovirus Vaccine Sales Value, 2019-2030

5.5.2 Europe Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Poliovirus Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Poliovirus Vaccine Sales Value, 2019-2030

5.7.2 South America Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Poliovirus Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Poliovirus Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Poliovirus Vaccine Sales Value

6.2.1 Key Countries/Regions Poliovirus Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Poliovirus Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Poliovirus Vaccine Sales Value, 2019-2030

6.3.2 United States Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Poliovirus Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Poliovirus Vaccine Sales Value, 2019-2030

6.4.2 Europe Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Poliovirus Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Poliovirus Vaccine Sales Value, 2019-2030

6.5.2 China Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Poliovirus Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Poliovirus Vaccine Sales Value, 2019-2030

6.6.2 Japan Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Poliovirus Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Poliovirus Vaccine Sales Value, 2019-2030

6.7.2 South Korea Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Poliovirus Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Poliovirus Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Poliovirus Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Poliovirus Vaccine Sales Value, 2019-2030

6.9.2 India Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Poliovirus Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Sanofi

7.1.1 Sanofi Company Information

7.1.2 Sanofi Introduction and Business Overview

7.1.3 Sanofi Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Sanofi Poliovirus Vaccine Product Offerings

7.1.5 Sanofi Recent Development

7.2 GSK

7.2.1 GSK Company Information

7.2.2 GSK Introduction and Business Overview

7.2.3 GSK Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 GSK Poliovirus Vaccine Product Offerings

7.2.5 GSK Recent Development

7.3 Bibcol

7.3.1 Bibcol Company Information

7.3.2 Bibcol Introduction and Business Overview

7.3.3 Bibcol Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Bibcol Poliovirus Vaccine Product Offerings

7.3.5 Bibcol Recent Development

7.4 Serum Institute

7.4.1 Serum Institute Company Information

7.4.2 Serum Institute Introduction and Business Overview

7.4.3 Serum Institute Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Serum Institute Poliovirus Vaccine Product Offerings

7.4.5 Serum Institute Recent Development

7.5 Tiantan Biological

7.5.1 Tiantan Biological Company Information

7.5.2 Tiantan Biological Introduction and Business Overview

7.5.3 Tiantan Biological Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Tiantan Biological Poliovirus Vaccine Product Offerings

7.5.5 Tiantan Biological Recent Development

7.6 IMBCA

7.6.1 IMBCA Company Information

7.6.2 IMBCA Introduction and Business Overview

7.6.3 IMBCA Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 IMBCA Poliovirus Vaccine Product Offerings

7.6.5 IMBCA Recent Development

7.7 Panacea Biotec Ltd

7.7.1 Panacea Biotec Ltd Company Information

7.7.2 Panacea Biotec Ltd Introduction and Business Overview

7.7.3 Panacea Biotec Ltd Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Panacea Biotec Ltd Poliovirus Vaccine Product Offerings

7.7.5 Panacea Biotec Ltd Recent Development

7.8 Bio-Med

7.8.1 Bio-Med Company Information

7.8.2 Bio-Med Introduction and Business Overview

7.8.3 Bio-Med Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Bio-Med Poliovirus Vaccine Product Offerings

7.8.5 Bio-Med Recent Development

7.9 Halfkin Bio-Pharmaceuticals

7.9.1 Halfkin Bio-Pharmaceuticals Company Information

7.9.2 Halfkin Bio-Pharmaceuticals Introduction and Business Overview

7.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Offerings

7.9.5 Halfkin Bio-Pharmaceuticals Recent Development

8 Industry Chain Analysis

8.1 Poliovirus Vaccine Industrial Chain

8.2 Poliovirus Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Poliovirus Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Poliovirus Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Sanofi

GSK

Bibcol

Serum Institute

Tiantan biological

IMBCA

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

List of Tables

Table 1. Poliovirus Vaccine Market Trends

Table 2. Poliovirus Vaccine Market Drivers & Opportunity

Table 3. Poliovirus Vaccine Market Challenges

Table 4. Poliovirus Vaccine Market Restraints

Table 5. Global Poliovirus Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Poliovirus Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Poliovirus Vaccine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Poliovirus Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Poliovirus Vaccine Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Poliovirus Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Poliovirus Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Poliovirus Vaccine

Table 13. Global Poliovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliovirus Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Poliovirus Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Poliovirus Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Poliovirus Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Poliovirus Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Poliovirus Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Poliovirus Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Poliovirus Vaccine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Poliovirus Vaccine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Poliovirus Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Poliovirus Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Poliovirus Vaccine Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Poliovirus Vaccine Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Poliovirus Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Poliovirus Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Poliovirus Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Poliovirus Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Poliovirus Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Poliovirus Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Poliovirus Vaccine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Poliovirus Vaccine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Poliovirus Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Poliovirus Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Poliovirus Vaccine Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Poliovirus Vaccine Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Poliovirus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Poliovirus Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Poliovirus Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Poliovirus Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Poliovirus Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Poliovirus Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Poliovirus Vaccine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Poliovirus Vaccine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Poliovirus Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Poliovirus Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Poliovirus Vaccine Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Poliovirus Vaccine Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Poliovirus Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Poliovirus Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Poliovirus Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Poliovirus Vaccine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Poliovirus Vaccine Sales Volume, (2025-2030) & (K Units)

Table 57. Sanofi Company Information

Table 58. Sanofi Introduction and Business Overview

Table 59. Sanofi Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Sanofi Poliovirus Vaccine Product Offerings

Table 61. Sanofi Recent Development

Table 62. GSK Company Information

Table 63. GSK Introduction and Business Overview

Table 64. GSK Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. GSK Poliovirus Vaccine Product Offerings

Table 66. GSK Recent Development

Table 67. Bibcol Company Information

Table 68. Bibcol Introduction and Business Overview

Table 69. Bibcol Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Bibcol Poliovirus Vaccine Product Offerings

Table 71. Bibcol Recent Development

Table 72. Serum Institute Company Information

Table 73. Serum Institute Introduction and Business Overview

Table 74. Serum Institute Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Serum Institute Poliovirus Vaccine Product Offerings

Table 76. Serum Institute Recent Development

Table 77. Tiantan Biological Company Information

Table 78. Tiantan Biological Introduction and Business Overview

Table 79. Tiantan Biological Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Tiantan Biological Poliovirus Vaccine Product Offerings

Table 81. Tiantan Biological Recent Development

Table 82. IMBCA Company Information

Table 83. IMBCA Introduction and Business Overview

Table 84. IMBCA Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. IMBCA Poliovirus Vaccine Product Offerings

Table 86. IMBCA Recent Development

Table 87. Panacea Biotec Ltd Company Information

Table 88. Panacea Biotec Ltd Introduction and Business Overview

Table 89. Panacea Biotec Ltd Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Panacea Biotec Ltd Poliovirus Vaccine Product Offerings

Table 91. Panacea Biotec Ltd Recent Development

Table 92. Bio-Med Company Information

Table 93. Bio-Med Introduction and Business Overview

Table 94. Bio-Med Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Bio-Med Poliovirus Vaccine Product Offerings

Table 96. Bio-Med Recent Development

Table 97. Halfkin Bio-Pharmaceuticals Company Information

Table 98. Halfkin Bio-Pharmaceuticals Introduction and Business Overview

Table 99. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Offerings

Table 101. Halfkin Bio-Pharmaceuticals Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Poliovirus Vaccine Downstream Customers

Table 105. Poliovirus Vaccine Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Poliovirus Vaccine Product Picture

Figure 2. Global Poliovirus Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Poliovirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Poliovirus Vaccine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Poliovirus Vaccine Sales Price (2019-2030) & (USD/Unit)

Figure 6. Poliovirus Vaccine Report Years Considered

Figure 7. Global Poliovirus Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Poliovirus Vaccine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Poliovirus Vaccine Revenue in 2023

Figure 10. Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Inactivated Polio Vaccine (IPV) Picture

Figure 12. Oral Polio Vaccine (OPV) Picture

Figure 13. Global Poliovirus Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Poliovirus Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Poliovirus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Poliovirus Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Poliovirus Vaccine Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Public

Figure 19. Product Picture of Private

Figure 20. Global Poliovirus Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Poliovirus Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Poliovirus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Poliovirus Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Poliovirus Vaccine Price by Application (2019-2030) & (USD/Unit)

Figure 25. North America Poliovirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Poliovirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Poliovirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Poliovirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Poliovirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Poliovirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Poliovirus Vaccine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Poliovirus Vaccine Sales Volume (%), (2019-2030)

Figure 37. United States Poliovirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Poliovirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Poliovirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Poliovirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Poliovirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Poliovirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Poliovirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Poliovirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Poliovirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Poliovirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Poliovirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Poliovirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Poliovirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Poliovirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Poliovirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 58. Poliovirus Vaccine Industrial Chain

Figure 59. Poliovirus Vaccine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Polio Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Polio Vaccination Market Research Report 2025

Global Poliomycetes Vaccine Market Insights Forecast to 2030

Global Poliomyelitis Therapeutics Market Insights Forecast to 2030

Chicken Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RSV Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Poliomyelitis Vaccine in Dragee Candy Market Research Report 2025

Duck Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inactivated Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Inactivated Polio Virus Vaccine Market Research Report 2025

Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Live Attenuated Polio Vaccine Market Research Report 2024

Pneumococcal Bacteria Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Japanese Encephalitis Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Combined Polio Vaccine Market Research Report 2024

Poultry Medicine and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mono Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bovine Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions